2024.04.27
In the field of biotechnology, ADME/TOX in vitro biological models have always been indispensable tools in the drug development process. With the advancement of drug research, the role of liver in vitro biological models, including Primary Hepatocytes and Liver Subcellular Fractions, as well hepatic 3D models, has become increasingly prominent. These models provide efficient and reliable methods for evaluating the metabolism, absorption, distribution, excretion, and toxicity of drugs in the body, playing a crucial role in various stages of drug development.
Among the top products in this field, MileCell Bio focuses on continuously innovating liver in vitro models. We will launch a series of articles on public media platforms to introduce the latest developments and flagship products of our company. We will delve into our excellent ADME/TOX liver in vitro models, including multi-species in vitro liver primary cells and hepatocyte subcellular products. These models are highly favored by scientists for their speed, accuracy, and high throughput in drug development. Additionally, we will explore the innovation and application of liver in vitro models in depth, revealing the frontier innovations in ADME/TOX technology.
Through this series of articles, MileCell Bio will provide professional information on in vitro models and the latest technological updates, showcasing our leading position and spirit of continuous innovation in the ADME/TOX field. Please stay tuned to our public media platforms as we explore the future of technology together and drive the development of scientific projects and drug development!
